Merck and Moderna announced on August 19, 2026, that their mRNA-based melanoma vaccine met its goals in a large clinical trial. The development represents significant progress in cancer immunotherapy and offers potential new treatment options for skin cancer patients.
No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.
Merck, Moderna say melanoma vaccine meets goals in large trial reuters.com
Progress on mRNA vaccine against melanoma sounds one of the few good news I read lately https://www. reuters.com/legal/litigation/m erck-moderna-say-melanoma-skin-cancer-vaccine-meets-goals-large-trial-2026-08-19/